Show
Sort by
-
- Journal Article
- A1
- open access
Clinical outcomes of second relapsed and refractory first relapsed paediatric AML : a retrospective study within the NOPHO‐DB SHIP consortium
-
ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells
-
- Journal Article
- A1
- open access
Shallow-depth sequencing of cell-free DNA for Hodgkin and diffuse large B-cell lymphoma (differential) diagnosis : a standardized approach with underappreciated potential
-
Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BMF AML Study Group and EWOG-MDS
-
- Journal Article
- A1
- open access
Direct oral anticoagulant removal by a DOAC filter : impact on lupus anticoagulant testing : evaluation on spiked and patient samples
-
Identifying patients with chronic lymphocytic leukemia without need of treatment : end of endless watch and wait?
-
- Journal Article
- A1
- open access
Prolonged remissions after nivolumab plus gemcitabine/oxaliplatin in relapsed/refractory T-cell lymphoma
-
Comparison of the effectiveness and safety of the oral selective inhibitor of nuclear export, selinexor, in diffuse large B cell lymphoma subtypes
-
Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma
-
- Journal Article
- A1
- open access
Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL : the HOVON-100 trial
-
CARTITUDE-2 cohort B : efficacy and safety of ciltacabtagene autoleucel, a chimeric antigen receptor T-cell therapy directed against B-cell maturation antigen, in patients with multiple myeloma and early relapse after initial treatment
(2022) BRITISH JOURNAL OF HAEMATOLOGY. In British Journal of Haematology 197(supplement 1). p.118-119 -
Exploration of the relationship between anemia and iron and zinc deficiencies in children under 5 years of age living in the malaria endemic area of South Kivu/Democratic Republic of Congo
-
- Journal Article
- A1
- open access
Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening : an international, multicentre, retrospective cohort study
-
Metallothioneins alter macrophage phenotype and represent novel therapeutic targets for acetaminophen-induced liver injury
-
- Journal Article
- A1
- open access
Direct and indirect anti-leukemic properties of Activity-on-Target interferons for the treatment of T-cell acute lymphoblastic leukemia
-
Monitoring of heparin therapy beyond the anti‐Xa activity assay : evaluation of a thrombin generation assay
-
Flow cytometric analysis of platelet function to detect high on‐treatment residual platelet reactivity in patients on dual antiplatelet therapy
-
- Journal Article
- A1
- open access
Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies : an EPICOVIDEHA survey report
-
CD8 presence and dynamics in glofitamab-treated patients with relapsed/refractory B-cell Non-Hodgkin lymphoma using the CD8-specific PET tracer Zr-89-crefmirlimab berdoxam
-
Ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR-T cell therapy, in patients with multiple myeloma (MM) and early relapse after initial therapy : CARTITUDE-2 cohort B 18-month follow-up